Here are eight things to know about Centinel’s third-quarter financial results, according to a Nov. 2 press release from the company:
1. Centinel has seen a 61% growth in global revenue year over year in the third quarter.
2. The company attributes its strong third-quarter results to a record number of Prodisc surgeon users and user adoption of its new Prodisc C Vivo and Prodisc C SK cervical disc replacement systems.
3. Its Prodisc cervical volume grew 75% over 2022, while the Prodisc lumbar volume grew 43%.
4. U.S. Prodisc cervical growth was over 100% in the third quarter.
5. As of the third quarter, almost 380 U.S. surgeons are using a Prodisc system.
6. Centinel achieved its 2,500th procedure using the new Prodisc C Vivo and Prodisc C SK system in September, just five months after its 1,000th case.
7. Prodisc total disc replacement revenue has reached $49 million year to date.
8. Looking ahead, the company predicts its total disc replacement business to exceed 50% year-over-year growth, outpacing its projected market growth of 11%.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
